- Home
- OCGN vs MTLS Comparison
OCGN vs MTLS Comparison
Compare OCGN & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- MTLS
- Stock Information
- Founded
- OCGN 2013
- MTLS 1990
- Country
- OCGN United States
- MTLS Belgium
- Employees
- OCGN N/A
- MTLS N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- MTLS Computer Software: Prepackaged Software
- Sector
- OCGN Health Care
- MTLS Technology
- Exchange
- OCGN Nasdaq
- MTLS Nasdaq
- Market Cap
- OCGN 278.3M
- MTLS 316.0M
- IPO Year
- OCGN N/A
- MTLS 2014
- Fundamental
- Price
- OCGN $0.92
- MTLS $5.61
- Analyst Decision
- OCGN Strong Buy
- MTLS
- Analyst Count
- OCGN 3
- MTLS 0
- Target Price
- OCGN $6.00
- MTLS N/A
- AVG Volume (30 Days)
- OCGN 8.5M
- MTLS 89.3K
- Earning Date
- OCGN 08-07-2025
- MTLS 07-30-2025
- Dividend Yield
- OCGN N/A
- MTLS N/A
- EPS Growth
- OCGN N/A
- MTLS 43.31
- EPS
- OCGN N/A
- MTLS 0.17
- Revenue
- OCGN $4,522,000.00
- MTLS $291,295,936.00
- Revenue This Year
- OCGN N/A
- MTLS $6.42
- Revenue Next Year
- OCGN N/A
- MTLS $8.33
- P/E Ratio
- OCGN N/A
- MTLS $32.92
- Revenue Growth
- OCGN N/A
- MTLS 6.16
- 52 Week Low
- OCGN $0.52
- MTLS $3.93
- 52 Week High
- OCGN $1.98
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- OCGN 55.00
- MTLS 53.42
- Support Level
- OCGN $0.95
- MTLS $5.25
- Resistance Level
- OCGN $1.15
- MTLS $5.58
- Average True Range (ATR)
- OCGN 0.11
- MTLS 0.18
- MACD
- OCGN -0.02
- MTLS -0.03
- Stochastic Oscillator
- OCGN 22.62
- MTLS 43.48
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.